Petra Hoppmann Person-Info 

( Ich bin Petra Hoppmann)

News

ISAR-ABSORB Registry Evaluates Everolimus-Eluting Bioresorbable...

citoday.com
April 26, 2016—The ISAR-ABSORB registry evaluated the angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents (BRS) in routine clinical practice. Petra Hoppmann, MD, et al published the results in Catheterization and Cardiovascular Interventions (2016;87:822–829).
Dossier exportieren
+1